company background image
AMT

Allegra OrthopaedicsASX:AMT Stock Report

Market Cap

AU$24.5m

7D

2.2%

1Y

67.9%

Updated

20 Oct, 2021

Data

Company Financials
AMT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

AMT Overview

Allegra Orthopaedics Limited designs, sells, and distributes medical device products in Australia and New Zealand.

Price History & Performance

Summary of all time highs, changes and price drops for Allegra Orthopaedics
Historical stock prices
Current Share PriceAU$0.23
52 Week HighAU$0.13
52 Week LowAU$0.65
Beta0.74
1 Month Change-6.00%
3 Month Change17.50%
1 Year Change67.86%
3 Year Change38.24%
5 Year Change161.11%
Change since IPO-58.04%

Recent News & Updates

Jan 27
What Does Allegra Orthopaedics' (ASX:AMT) CEO Pay Reveal?

What Does Allegra Orthopaedics' (ASX:AMT) CEO Pay Reveal?

This article will reflect on the compensation paid to Jenny Swain who has served as CEO of Allegra Orthopaedics Limited...

Dec 05
We Think Allegra Orthopaedics (ASX:AMT) Can Easily Afford To Drive Business Growth

We Think Allegra Orthopaedics (ASX:AMT) Can Easily Afford To Drive Business Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Shareholder Returns

AMTAU Medical EquipmentAU Market
7D2.2%3.0%1.7%
1Y67.9%-6.5%20.2%

Return vs Industry: AMT exceeded the Australian Medical Equipment industry which returned -6.5% over the past year.

Return vs Market: AMT exceeded the Australian Market which returned 20.2% over the past year.

Price Volatility

Is AMT's price volatile compared to industry and market?
AMT volatility
AMT Beta0.74
Industry Beta0.57
Market Beta1

Stable Share Price: AMT is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 13% a week.

Volatility Over Time: AMT's weekly volatility has decreased from 24% to 13% over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
1994n/aJenny Swainhttps://www.allegraorthopaedics.com

Allegra Orthopaedics Limited designs, sells, and distributes medical device products in Australia and New Zealand. It operates in two segments, Orthopedics Division and Innovation Division. The company provides adult and adolescent clavicle fixation systems; a range of symmetrical and asymmetrical offsets for shoulder; and StripEase, distal radius systems, compression screws, hand fracture systems, ulna shortening plates, and modular ceramic or CoCr heads for hand and wrist.

Allegra Orthopaedics Fundamentals Summary

How do Allegra Orthopaedics's earnings and revenue compare to its market cap?
AMT fundamental statistics
Market CapAU$24.55m
Earnings (TTM)-AU$578.84k
Revenue (TTM)AU$6.30m

3.9x

P/S Ratio

-42.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AMT income statement (TTM)
RevenueAU$6.30m
Cost of RevenueAU$1.87m
Gross ProfitAU$4.43m
ExpensesAU$5.01m
Earnings-AU$578.84k

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.0055
Gross Margin70.25%
Net Profit Margin-9.19%
Debt/Equity Ratio6.4%

How did AMT perform over the long term?

See historical performance and comparison

Valuation

Is Allegra Orthopaedics undervalued compared to its fair value and its price relative to the market?

5.37x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate AMT's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate AMT's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: AMT is unprofitable, so we can't compare its PE Ratio to the Australian Medical Equipment industry average.

PE vs Market: AMT is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AMT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AMT is overvalued based on its PB Ratio (5.4x) compared to the AU Medical Equipment industry average (5x).


Future Growth

How is Allegra Orthopaedics forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allegra Orthopaedics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Allegra Orthopaedics performed over the past 5 years?

-4.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AMT is currently unprofitable.

Growing Profit Margin: AMT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AMT is unprofitable, and losses have increased over the past 5 years at a rate of 4.3% per year.

Accelerating Growth: Unable to compare AMT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AMT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (74.9%).


Return on Equity

High ROE: AMT has a negative Return on Equity (-12.66%), as it is currently unprofitable.


Financial Health

How is Allegra Orthopaedics's financial position?


Financial Position Analysis

Short Term Liabilities: AMT's short term assets (A$4.8M) exceed its short term liabilities (A$1.6M).

Long Term Liabilities: AMT's short term assets (A$4.8M) exceed its long term liabilities (A$165.3K).


Debt to Equity History and Analysis

Debt Level: AMT's debt to equity ratio (6.4%) is considered satisfactory.

Reducing Debt: AMT's debt to equity ratio has reduced from 46.3% to 6.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AMT has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: AMT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.5% each year


Dividend

What is Allegra Orthopaedics's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AMT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AMT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AMT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AMT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AMT's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.8yrs

Average management tenure


CEO

Jenny Swain

5.42yrs

Tenure

AU$381,737

Compensation

Ms. Jenny Swain has been the Chief Executive Officer of Allegra Orthopaedics Limited since May 2, 2016. Ms. Swain served as Director Sales and Marketing of Allegra Orthopaedics Limited and served as its Na...


CEO Compensation Analysis

Compensation vs Market: Jenny's total compensation ($USD285.41K) is about average for companies of similar size in the Australian market ($USD302.06K).

Compensation vs Earnings: Jenny's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: AMT's management team is considered experienced (4.8 years average tenure).


Board Members

Experienced Board: AMT's board of directors are considered experienced (6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Allegra Orthopaedics Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Allegra Orthopaedics Limited
  • Ticker: AMT
  • Exchange: ASX
  • Founded: 1994
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: AU$24.548m
  • Shares outstanding: 104.46m
  • Website: https://www.allegraorthopaedics.com

Location

  • Allegra Orthopaedics Limited
  • 18-20 Orion Road
  • Level 8
  • Lane Cove West
  • New South Wales
  • 2066
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/20 07:02
End of Day Share Price2021/10/19 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.